Abstract Human immunodeficiency virus (HIV) affects the vital cells of the immune system eventually leading to a fall in the cell mediated immunity. As the disease progresses CD 4
Introduction
Acquired immune deficiency syndrome (AIDS) is the end stage of the disease process caused by human immune deficiency virus (HIV). Since the first reported cases in 1981 (USA), 1986 (INDIA) [2] this retrovirus has taken the form of a pandemic. HIV has been given this name because of its long-term effect, to attack the immune system of the body, making it weak and deficient.
HIV infects vital cells in the human immune system such as helper T cells (specifically CD 4 ? T cells), macrophages, and dendritic cells [3] . HIV infection leads to low levels of CD 4 ? T cells through a number of mechanisms including: apoptosis of uninfected bystander cells [4] , direct viral killing of infected cells, and killing of infected CD 4 ? T cells by CD 8 ? cytotoxic lymphocytes that recognize infected cells [5] . When CD 4 ? T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections. As the CD 4 ? count drops below 200 cells/mm 3 , patients become vulnerable to many of the processes associated with AIDS.
The disease mirrors the immune system, with decrease in CD 4 count the spectrum also changes. This study was conducted to evaluate the spectrum of otorhinolaryngological manifestations in HIV positive patients with their CD 4 count at the time of presentation. The study aimed at identifying certain trends that could alert the clinician to start prompt treatment, to prevent further progression.
Materials and Methods
This clinical study was conducted from July 2008 to November 2011, wherein 100 patients attending ART clinic, were randomly selected. After consent and maintaining complete secrecy of the identity of the patient, a full otorhinolaryngological examination was done. All patients who were confirmed to be HIV positive on treatment (HAART) or without treatment were included in the study. A through ENT examination was done. Data was collected, tabulated and analysed.
Observations
A total of 100 patients were examined. The commonest age group of presentation was 30-39 years ( Table 1 ). The male to female ratio was 3:1, with the predominant mode of transmission being heterosexual contact (83 %). Other modes of transmission being intravenous drug abuse (10 %), blood transfusion (4 %) and mother to child transmission (3 %) ( Table 2) .
Clinical examination revealed otorhinolaryngological manifestations in (76 %) of patients. Oropharyngeal manifestations were the commonest at (48 %) in the 100 patients examined. Oral candidiasis was seen in (20 %) of the 100 patients with a mean CD 4 ? count of 187 (Table 3) . Neck nodes were found in (20 %) with a mean CD 4 ? count of 239. Otological findings were positive in (31 %) of the patients. The commonest ear manifestation was a retracted tympanic membrane (13 %) with a mean CD 4 ? count of 376 (Table 4) . Nasal pathology was found in (18 %) with commonest being rhinosinusitis, with mean CD 4 ? count of 293 (Table 5) .
In patients with candidiasis, epistaxis and otitis externa the CD 4 ? counts were below 200 which is considered to define AIDS as per CDC classification.
On systemic examination and investigation 32 % had tuberculosis (pulmonary/extrapulmonary or both), 4 % were HB s Ag (Hepatitis B surface antigen) positive and 1 % was VDRL (Venereal Disease Research Laboratory) test positive.
Discussion
HIV infection has four basic stages: incubation period, acute infection, latency stage and AIDS. The first stage of infection, the primary, or acute infection, is a period of ? T cells, which kill HIV-infected cells. There is subsequently antibody production and seroconversion. During this period (usually 2-4 weeks post-exposure) most individuals (80-90 %) develop an influenza or mononucleosis-like illness [6, 7] called acute HIV infection, the most common symptoms of which may include fever, lymphadenopathy, pharyngitis, rash, myalgia, malaise, mouth and esophageal sores [7] .
A strong immune defense reduces the number of viral particles in the blood stream, marking the start of the infection's clinical latency stage. During this early phase of infection, HIV is active within lymphoid organs, where large amounts of virus become trapped in the follicular dendritic cells network.
When CD 4 ? T cell numbers decline below a critical level of 200 cells per lL, cell-mediated immunity is lost, and infections with a variety of opportunistic microbes appear. The first symptoms often include moderate and unexplained weight loss, recurring respiratory tract infections (such as sinusitis, bronchitis, otitis media, pharyngitis), skin rashes, and oral ulcerations.
CDC has classified [8] HIV on the basis of the lowest recorded CD 4 ? count and the presence of symptoms into A, B, C categories is used for treatment purposes. Where CD 4 ? counts are not possible WHO classification based on clinical features is used to classify patients in 1-4 clinical stages [9] .
All these classification systems are to make the treatment protocols simpler depending on the level of strength of the immune system. The timing of when to initiate therapy has continued to be a core controversy within the medical community. The WHO recommendations (2013) [10] are to start HAART (Highly active antiretroviral therapy) in WHO clinical stage 3 and 4 patients, or if the CD 4 ? count is below B500, co infection with HBV(Hepatitis B Virus), active tuberculosis and serodiscordant couples, all pregnant women, all children below 5 years of age.
In our study of the 100 patients 75 were on HAART, with majority of patients being on treatment the incidence of infection was lesser. The spectrum of diseases was also narrowed.
In our study the peak incidence of HIV was in 30-39 age group with a male to female ration of 3:1 which was comparable to other studies of Deb et al. [11] and Prasad et al. [12] (Table 1) .
The mode of transmission was found to be heterosexual (83 %) ( Table 2 ). Where as Deb et al. in their study ''Head and neck manifestations of HIV infection: a preliminary study'' done in Manipur reported Intravenous Drug abuse as the commonest mode of transmission (65 %). H Kishore Chandra Prasad etal in their study ''HIV manifestations in otolaryngology'' done in Mangalore, Karnataka reported heterosexual mode as the commonest (65 %). Probably due to different cultural scenario and incidence of Intravenous drug abuse the mode of transmission was found to be variable.
The incidence of otorhinolaryngological manifestations in HIV positive patients was (76 %) comparable to Kishore Chandra Prasad et al. (79 %) [12] . A higher incidence was reported in studies done in paediatric population Hadfield et al. (91 %) [13] and Michael A Williams et al. (80 %) [14] .
Oropharyngeal candidiasis was the commonest presentation (20 %) which was lesser than the incidence of 40 % reported by Kishore Chandra Prasad [12] . The mean CD 4 ? count were 187 ( Table 3 ), reaffirming that CD 4 ? counts below 200 opportunistic infections become common.
The commonest otological presentation which brought the patient was chronic suppurative otitis media (12 %). On examination of all the patients a higher incidence of retraction of tympanic membrane was found (13 %) than otitis media, probably attributable to eustachian tube dysfunction. The mean CD 4 ? count in case of chronic otitis media was 193 were as retracted tympanic membrane was found at a higher CD 4 ? count of 376 (Table 4) . These changes should alert the physician to treat an upper respiratory tract infection promptly to prevent development of acute otitis media in patients with pre existing eustachian tube dysfunction.
Sensorineural loss is associated with development of full blown AIDS mostly in patients with otosyphilis. In our study one patient was found to be VDRL positive, with no evidence of sensorineural hearing loss with tuning fork test.
Nasal pathology was found in (18 %) of the patients. Rhinosinusitis in (14 %) was comparable to (17 %) as reported by Kishore Chandra Prasad. The mean CD 4 ? counts were 293 in patients with rhinosinusitis. Epistaxis was found at a mean CD 4 ? count of 139 (Table 5) . Neck nodes were seen in (20 %) of the patients of which (13 %) were tubercular remaining being non specific. Variable results have been published from different parts of the world Michael A William reported (60 %) patients had neck nodes. Kishore Chandra Prasad reported (42 %). Alabi [15] had (9 %) incidence.
Hadderringh [16] ''otorhinolaryngological findings in AIDS patients:a study of 63 cases'' done in 1982 reported equal incidence of Kaposi sarcoma in male and female. No cases of Kaposi sarcoma and non hodgkins lymphoma associated with HIV were found in the head and neck region in our study. 75 out of the 100 patients study were receiving HAART at the time of examination. The availability of low cost drugs and increased awareness the timely administration of HAART had decreased the incidence of candidiasis. HA-ART suppresses the HIV multiplication and progress of infection such that CD 4 ? counts are maintained, opportunistic infections only set in when the count falls below 200.
Conclusion
The HIV positive patients should be regularly followed with the otorhinolaryngologist. As early changes in the ear, nose, pharynx and neck can be detected. The nose and throat are the portals of entry of many organisms into the body. Eminent fall in CD 4 count can be anticipated in view of the clinical presentation, and timely HAART can be started, before further worsening takes place.
The otorhinolaryngologist should be well aware of the wide range of presentation coupled with a high index of suspicion can enhance testing and diagnosis. HAART has improved the life expectancy of HIV patients and reduced the incidence of life threatening complications.
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